| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |